聚合内容 The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
更新时间: 55 分钟 12 秒 前

Monteris Medical Announces Appointment Of Martin J. Emerson As President and Chief Executive Officer

周二, 07/19/2016 - 15:12
PLYMOUTH, Minn., July 19, 2016 -- (Healthcare Sales & Marketing Network) -- Monteris Medical today announced that its Board of Directors has appointed Martin J. Emerson as its President and Chief Executive Officer effective immediately. Monteris Medical ...
Devices, Oncology, Neurosurgery, Personnel
Monteris Medical, NeuroBlate

Preceptis Medical Launches the Hummingbird(TM) TTS Ear Tube Delivery System

周二, 07/19/2016 - 15:07
PLYMOUTH, Minn., July 19, 2016 -- (Healthcare Sales & Marketing Network) -- Preceptis Medical announces its U.S. limited market launch of the Hummingbird TTS (Tympanostomy Tube System) that uses conscious (moderate) sedation for children's ear tube placem...
Devices, Product Launch
Preceptis Medical, Hummingbird, Tympanostomy Tube

Platinum Diagnostic Lab Announces the Availability of Thermo Scientific ImmunoCAP(TM) Allergy Testing Products

周二, 07/19/2016 - 14:50
LINDEN, N.J., July 18, 2016 -- (Healthcare Sales & Marketing Network) -- Platinum Diagnostic Lab announces the availability of Thermo Scientific ImmunoCAP™ allergy testing products. ImmunoCAP measures the concentration of immunoglobulin E (IgE), which is ...
Diagnostics, Product Launch
Platinum Diagnostic Lab, ImmunoCAP, immunoglobulin E

Citius Pharmaceuticals Completes Feasibility Study of Investigator Sites for Mino-Lok(TM) Phase 3 Trials

周一, 07/18/2016 - 15:25
CRANFORD, N.J., July 18, 2016 -- (Healthcare Sales & Marketing Network) -- Citius Pharmaceuticals, Inc. ("Citius") (OTC BB: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced to...
Biopharmaceuticals
Citius Pharmaceuticals, Mino-Lok, CRBSI

Essential Medical Inc. Announces CE Mark Approval for the MANTA(TM) Large Bore Vascular Closure Device

周一, 07/18/2016 - 15:24
MALVERN, Pennsylvania, July 18, 2016 -- (Healthcare Sales & Marketing Network) -- Essential Medical, Inc., a privately held medical device company addressing the rapidly growing large bore vascular closure market, announced today that it has received CE M...
Devices, Interventional, Regulatory
Essential Medical, MANTA, Vascular Closure

Genentech Provides Update on Phase III Study of Gazyva(R) in People With Previously Untreated Diffuse Large B-Cell Lymphoma

周一, 07/18/2016 - 15:06
SOUTH SAN FRANCISCO, Calif.--(Healthcare Sales & Marketing Network)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) today announced that the Phase III GOYA study evaluating Gazyva® (obinutuzumab) plus CHOP chemotherapy (G-CHOP) in ...
Biopharmaceuticals, Oncology
Genentech, Gazyva, obinutuzumab

Medifirst Solutions Is Granted 510(k) FDA Clearance

周五, 07/15/2016 - 15:24
FREEHOLD, NJ--(Healthcare Sales & Marketing Network) - MEDIFIRST SOLUTIONS, INC. ( OTC PINK : MFST ) (the "Company" or "Medifirst") would like to update shareholders regarding a major company development. On July 8, 2016, Medifirst Solu...
Devices, Dermatology, FDA
Medifirst Solutions, medical lasers

Bach Pharma Appoints Kelly Blackburn as Chief Executive Officer

周五, 07/15/2016 - 13:28
NORTH ANDOVER, Mass., July 15, 2016 -- (Healthcare Sales & Marketing Network) -- Bach Pharma Inc., today announced the appointment of Kelly Blackburn as Chief Executive Officer and as a member of the Bach Pharma Board of Directors. Ms. Blackburn will lea...
Biopharmaceuticals, Personnel
Bach Pharma, phthalazinedione

Ardelyx to Raise $110 Million in a Private Placement

周五, 07/15/2016 - 13:20
FREMONT, Calif., July 15, 2016 -- (Healthcare Sales & Marketing Network) -- Ardelyx, Inc. (ARDX), a clinical-stage biopharmaceutical company focused on gastrointestinal and cardio-renal diseases, today announced that it has entered into an agreement to se...
Biopharmaceuticals, Venture Capital
Ardelyx, tenapanor

Leica Microsystems Introduces A New Distribution Partner, Angstrom Scientific

周五, 07/15/2016 - 13:10
BUFFALO GROVE, Ill., July 15, 2016 -- (Healthcare Sales & Marketing Network) -- Leica Microsystems, a technology leader with a 160-year history of providing best-in-class precision microscopy, electron microscopy (EM) sample preparation and digital micro-...
Devices, Distribution
Leica Microsystems, Angstrom Scientific

REVLIMID(R) (Lenalidomide) Approved by the European Commission for the Treatment of Relapsed/Refractory Patients with Mantle Cell Lymphoma

周五, 07/15/2016 - 13:02
BOUDRY, Switzerland--(Healthcare Sales & Marketing Network)--Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation (CELG) today announced that the European Commission (EC) has approved REVLIMID® (lenalidomide) for the trea...
Biopharmaceuticals, Oncology, Regulatory
Celgene, REVLIMID, lenalidomide, mantle cell lymphoma

Peregrine Licenses Novel Exosome-Based Cancer Detection and Monitoring Technology from UT Southwestern Medical Center

周四, 07/14/2016 - 16:18
New Technology Efficiently Builds on the Company’s Existing Phosphatidylserine (PS) Targeting Platform and Assay Development Capabilities Stand Alone Program That Offers Significant Value Creation Potential and Early Partnering Opportunities New Tech...
Biopharmaceuticals, Diagnostics, Oncology, Licensing
Peregrine Pharmaceuticals, exosome

Bayer Announces the Launch of Aleve(R) Direct Therapy(TM) TENS Device to Help People who Suffer from Lower Back Pain

周四, 07/14/2016 - 16:14
WHIPPANY, N.J., July 14, 2016 -- (Healthcare Sales & Marketing Network) -- Today, Bayer announced that Aleve® Direct Therapy™, a safe, drug-free, pain relief device, is now available at retailers nationwide in the analgesics aisle. Aleve Direct Therap...
Devices, Product Launch
Bayer, Aleve Direct Therapy, Transcutaneous Electrical Nerve Stimulation

Accuray Products Continue to Receive Highest Composite User Satisfaction Ratings in Latest MD Buyline Report

周四, 07/14/2016 - 13:47
SUNNYVALE, Calif., July 14, 2016 -- (Healthcare Sales & Marketing Network) -- Accuray Incorporated (ARAY) announced today that its CyberKnife® and TomoTherapy® Systems continue to set the standard for overall user satisfaction. The Accuray system...
Devices, Oncology, Neurosurgery
Accuray, CyberKnife, TomoTherapy, radiotherapy, radiosurgery

Amgen And Daiichi Sankyo Announce Agreement To Commercialize Biosimilars In Japan

周四, 07/14/2016 - 13:39
THOUSAND OAKS, Calif. and TOKYO, July 13, 2016 -- (Healthcare Sales & Marketing Network) -- Amgen (AMGN) and Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo; TSE: 4568) today announced the execution of an exclusive agreement to commercialize ni...
Biopharmaceuticals
Amgen, Daiichi Sankyo, biosimilars, adalimumab, bevacizumab, trastuzumab

Second Genome Appoints Glenn Nedwin, Ph.D., as Chief Executive Officer

周三, 07/13/2016 - 15:13
SOUTH SAN FRANCISCO, Calif., July 13, 2016 -- (Healthcare Sales & Marketing Network) -- Second Genome, Inc., a privately-held biopharmaceutical company developing novel medicines through innovative microbiome science, today announced the appointment of Gl...
Biopharmaceuticals, Personnel
Second Genome, microbiome

TELA Bio Announces Commercial Launch of OviTex(TM) Reinforced BioScaffolds for Ventral Hernia Repair and Abdominal Wall Reconstruction

周三, 07/13/2016 - 15:11
MALVERN, Pa., July 13, 2016 -- (Healthcare Sales & Marketing Network) -- TELA Bio, Inc., a surgical reconstruction company leading the development of Reinforced BioScaffolds (RBSs) for soft tissue repair, today announced the commercial launch of the compa...
Devices, Surgery, Product Launch
TELA Bio, BioScaffold, OviTex, hernia repair

CytoSorbents Teams with Medial and Meditrade to Bring CytoSorb(R) to Hungary, Czech Republic, Slovakia, and Poland

周三, 07/13/2016 - 14:01
MONMOUTH JUNCTION, N.J., July 13, 2016 -- (Healthcare Sales & Marketing Network) -- CytoSorbents Corporation (CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to treat deadly inflammation in critically-il...
Devices, Distribution
CytoSorbents, CytoSorb, blood filter

Lilly and Boehringer Ingelheim Announce Clinical Trial Collaboration in Metastatic Breast Cancer

周三, 07/13/2016 - 13:55
INDIANAPOLIS, July 13, 2016 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (LLY) and Boehringer Ingelheim today announced a new collaboration on a Phase 1b study that will evaluate the safety and tolerability of abemaciclib (LY2835219)...
Biopharmaceuticals, Oncology
Eli Lilly, Boehringer Ingelheim, abemaciclib, breast cancer

Decibel Therapeutics Appoints Steven H. Holtzman as President and Chief Executive Officer

周三, 07/13/2016 - 13:48
CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Decibel Therapeutics, a hearing company focused on discovering and developing new therapies to protect, repair and restore hearing, today announced the appointment of industry veteran Steven H. Holt...
Devices, Personnel
Decibel Therapeutics

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong